OROPHARYNGEAL CARCINOMA
Clinical trials for OROPHARYNGEAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNGEAL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNGEAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could less radiation be enough for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether giving lower doses of radiation over a shorter time, along with standard chemotherapy, works as well as the usual higher radiation doses for people with HPV-positive throat cancer. About 74 participants will receive chemoradiation with drugs like cis…
Matched conditions: OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Could less radiation be just as good for HPV throat cancer?
Disease control Recruiting nowThis study is testing whether a much lower dose of radiation (30 Gy) combined with standard chemotherapy can control HPV-positive throat cancer as well as the usual high dose (70 Gy). The goal is to reduce side effects from radiation while still keeping the cancer from coming bac…
Matched conditions: OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Promising trial aims to spare throat cancer patients from unnecessary radiation
Disease control Recruiting nowThis study tests whether people with HPV-positive throat cancer can safely receive a lower dose of radiation if their tumor shrinks quickly during early treatment. About 120 participants will be monitored for 2 years to see if the reduced treatment still prevents cancer from comi…
Matched conditions: OROPHARYNGEAL CARCINOMA
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Throat cancer diagnosis could get faster and more accurate with new ultrasound technique
Diagnosis Recruiting nowThis study tests whether adding a special ultrasound of the tonsils to standard exams helps doctors diagnose oropharyngeal cancer more accurately. About 180 patients with suspected throat cancer will be randomly assigned to either standard diagnostics alone or standard diagnostic…
Matched conditions: OROPHARYNGEAL CARCINOMA
Phase: NA • Sponsor: Tobias Todsen • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Can steroids reverse nerve damage from cancer radiation?
Symptom relief Recruiting nowThis study tests high-dose steroids (methylprednisolone or prednisone) in 35 head and neck cancer survivors who have nerve damage from past radiation. The goal is to find the best dose that improves symptoms like tongue weakness while limiting side effects. Participants must be a…
Matched conditions: OROPHARYNGEAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Stanford launches massive study to track oropharyngeal cancer over time
Knowledge-focused Recruiting nowThis study aims to learn more about oropharyngeal carcinoma, a type of throat cancer that can be linked to HPV. Researchers will collect blood samples from 1,000 patients before treatment and at six follow-up visits, and also gather tumor tissue when available. The goal is to bet…
Matched conditions: OROPHARYNGEAL CARCINOMA
Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC